Crescita Therapeutics Inc.

CRRTF · OTC
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Operating Activities
Net Income$753$798-$932-$162
Dep. & Amort.$384$353$353$365
Deferred Tax$0$0$0-$14
Stock-Based Comp.$7$28$30$17
Change in WC$706-$1,052$146$1,111
Other Non-Cash-$677-$130-$110$59
Operating Cash Flow$1,173-$3-$513$1,376
Investing Activities
PP&E Inv.-$46-$170-$66-$353
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$775$0$0$0
Investing Cash Flow-$821-$170-$66-$353
Financing Activities
Debt Repay.-$118-$116-$116-$113
Stock Issued$0$0$0$0
Stock Repurch.-$121-$59-$43-$77
Dividends Paid$0$0$0$0
Other Fin. Act.$0$0$0-$50
Financing Cash Flow-$239-$175-$159-$240
Forex Effect$11-$6$3$52
Net Chg. in Cash$124-$354-$735$835
Supplemental Information
Beg. Cash$8,184$8,538$9,273$8,438
End Cash$8,308$8,184$8,538$9,273
Free Cash Flow$1,127-$173-$579$1,023
Crescita Therapeutics Inc. (CRRTF) Financial Statements & Key Stats | AlphaPilot